InsiderTrades

Form 4 for EXEL EXELIXIS, INC.

Accepted 2025-02-28 00:00:00 ET · period of report 2025-02-28 · accession 0000939767-25-000039 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-02-28 2025-02-28 EXEL WYSZOMIERSKI JACK L Dir S - Sale+OE $37.80 -8,768 356.6K -2% -$331.4K
D 2025-02-28 2025-02-28 EXEL WYSZOMIERSKI JACK L Dir M - OptEx $20.50 +15.9K 365.4K +5% +$325.4K
D 2025-02-28 2025-02-28 EXEL WYSZOMIERSKI JACK L Dir M - OptEx $0.00 -15.9K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-02-28 S D 8,768 $37.80 356,605 D — — (F1) Includes 18,838 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
2 Common Common Stock 2025-02-28 M A 15,874 $20.50 365,373 D — — (F1) Includes 18,838 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
3 Derivative Option (right to buy) 2025-02-28 M D 15,874 $0.00 0 D $20.50 · 2018-05-24 to 2025-05-23 15,874 Common Stock (F3) The option, representing the right to purchase a total of 15,874 shares of Common Stock, became fully exercisable on May 24, 2018.